Stock prices continue to climb to new all-time highs even as expectations for earnings come down. These two opposing forces have caused valuations — as measured by the price/earnings (P/E) ratio — to ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...

Elanco Animal Health has faced revenue declines and suffered from high debt, creating a challenging operating environment. The company's performance has been disappointing, with missed synergy targets ...

KeyBanc initiates Elanco with an Overweight rating, citing strong Innovation Product growth, margin gains, and a path to ...

Elanco Animal Health's stock declined 26%, but despite improved financials, high debt levels and limited growth opportunities make it a cautious investment. Fiscal 2024 saw slight revenue growth and a ...

Margin expansion is anticipated from both an increasing companion animal revenue mix and the company’s Ascend cost savings program. Notably, Elanco has already reduced its leverage ratio from ...

Elanco Animal Health Incorporated (ELAN) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in ...

Elanco Animal Health (NYSE:ELAN) is at a 52-week high after the company’s first-quarter earnings release. Not only did the animal health company beat consensus expectations, but it also provided ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...